• NICE expands its recommendation for Oncotype Dx test pharmaceutical-technology
    December 20, 2018
    The UK’s pricing regulator the National Institutes of Health and Care Excellence (NICE) has expanded its guidance for Genomic Health’s Oncotype Dx Breast Recurrence Score to include early lymph node (LN)-negative breast cancer......
PharmaSources Customer Service